The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,...

The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and...

MAC Clinical Research featured in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills. The...

To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in the...

Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase...

MAC are excited to be collaborating with DemeRx on their phase 1 trial of Opioid Use Disorder.

MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s...

MAC Clinical Research the UK’s leading clinical trials organisation is proud to announce achieving Cyber Essentials security industry certif

Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced...

Dr John Connell (Chief Scientific Officer) and MAC's wider team of clinical development experts attended this years Clinical Trials...